Some life tests are terminated with few or no failures. In such cases, a recent approach is to obtain degradation measurements of product performance that may contain some useful information about product reliability. Generally degradation paths of products are modeled by a nonlinear regression mode
NON-PARAMETRIC INFERENCE OF A FAILURE TIME DISTRIBUTION WHEN THE FAILURE TIMES ARE ESTIMATED
โ Scribed by HYUNGJIN MYRA KIM; STEPHEN W. LAGAKOS
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 925 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0277-6715
No coin nor oath required. For personal study only.
โฆ Synopsis
We consider the estimation of a failure time distribution F when, instead of N i.i.d. realizations TI, T z , .. . , T N from F, the observations consist of estimates of the Ti. If the T i could be observed, a natural non-parametric estimator of F would be the Kaplan-Meier estimator. Thus, we examine the properties of the Kaplan-Meier estimator based on the estimates of the Ti. We also consider a weighted Kaplan-Meier estimator which gives more emphasis to those estimated times based on more information. We evaluate the small sample bias and precision of F when the estimated failure times arise from additive or multiplicative error structures. Because this problem has particular application in the study of non-compliance of subjects in clinical trials, we also investigate the bias and precision of the estimators of the distribution function based on a complex error structure that would arise in the non-compliance setting. Here T i denotes the unobserved time to non-compliance for the ith subject, and is estimated using repeated observations from a laboratory marker whose behaviour is affected by non-compliance. The techniques are illustrated with the results of a recent AIDS clinical trial.
๐ SIMILAR VOLUMES
We conducted a simulation study to compare two semi-parametric approaches for the estimation of covariate effects from multivariate failure time data. The first approach was developed by Wei, Lin and Weissfeld (WLW) and the second by Liang, Self and Chang (LSC). Based on the simulation results we re
Researchers commonly express scepticism about using observational data to estimate the effect of a treatment on an outcome the treatment is intended to affect. In this paper, we consider using data from the Multicenter AIDS Cohort Study (MACS) to determine whether zidovudine prevents the development